Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2019 08:00 ET | Source: iCAD, Inc.

iCAD Reports First Quarter 2019 Financial Results

U.S. adoption of ProFound AI™, the Company’s deep-learning cancer detection software solution for digital breast tomosynthesis, gaining traction Conference call today at 8:30 a.m. ET NASHUA, N.H.,...
May 06, 2019 08:00 ET | Source: iCAD, Inc.

iCAD Appoints R. Scott Areglado as Chief Financial Officer

NASHUA, N.H., May 06, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today appointed R. Scott...
May 01, 2019 16:05 ET | Source: iCAD, Inc.

iCAD to Report First Quarter 2019 Financial Results on Tuesday, May 7

NASHUA, N.H., May 01, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will...
April 15, 2019 08:00 ET | Source: iCAD, Inc.

iCAD Wins Three-System Public Bid with Leading Cancer Organization in Spain, Expanding European Access to Innovative Cancer Treatments with the Xoft System

Two additional Spanish centers announce adoption of the Xoft System, totaling seven installations across four major regions in Spain Internationally-recognized institutions strengthen portfolio of...
April 04, 2019 10:53 ET | Source: iCAD, Inc.

iCAD to Highlight ProFound AI™ Solution for Digital Breast Tomosynthesis at 2019 Society of Breast Imaging Annual Symposium

NASHUA, N.H., April 04, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
March 28, 2019 08:22 ET | Source: iCAD, Inc.

iCAD Appoints Stacey Stevens as President

Appointment establishes executive infrastructure to enhance strategic and operational momentum and capitalize on significant growth opportunities Announcement follows pivotal FDA clearance and...
March 26, 2019 08:00 ET | Source: iCAD, Inc.

iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit

NASHUA, N.H., March 26, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
March 18, 2019 16:01 ET | Source: iCAD, Inc.

iCAD Reports Fourth Quarter and Full-Year 2018 Financial Results

Company achieved key milestone in fourth quarter with FDA clearance and subsequent U.S. commercial launch of ProFound AI™ for digital breast tomosynthesis Conference call today at 4:30 p.m. ET ...
March 14, 2019 08:00 ET | Source: iCAD, Inc.

iCAD to Present Corporate Overview at the 31st Annual ROTH Conference

NASHUA, N.H., March 14, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
March 13, 2019 16:30 ET | Source: iCAD, Inc.

iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18

NASHUA, N.H., March 13, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...